Corteva, Inc. Quarterly Report Released - Here’s What You Should Know

Corteva, Inc. Q3 2025 Summary Report

Key Financial Results:

• Q3 2025 Net Sales: $2,618 million (up 13% vs. Q3 2024’s $2,326 million), driven by 12% volume growth and positive pricing.
• YTD September 2025 Net Sales: $13,491 million (up 4% vs. $12,930 million in 2024).
• Q3 2025 Net Loss: $(318) million (improved from $(521) million in Q3 2024).
• YTD Net Income: $1,654 million (vs. $958 million same period 2024), net income attributable to Corteva was $1,646 million.
• Basic EPS YTD: $2.41 (up from $1.36 in 2024).
• Q3 EPS: $(0.47) vs. $(0.76) in Q3 2024.
• Operating EBITDA (Non-GAAP):
  • Q3 2025: $49 million (improved from $(100) million in Q3 2024)
  • YTD: $3,402 million (up from $2,851 million in 2024)
• Operating cash flow YTD: $(941) million (improved vs. $(1,871) million 2024)

Segment Performance:

• Seed Segment:
  • Q3 Net Sales: $917 million (up 33%)
  • YTD Net Sales: $8,161 million (up 5%)
  • Q3 Operating EBITDA: $(193) million (improved from $(320) million)
  • YTD Operating EBITDA: $2,512 million (up 18%)
  • Growth in corn sales (Q3 up $271 million, +86%), strong pricing and volume in North America and Latin America.
• Crop Protection Segment:
  • Q3 Net Sales: $1,701 million (up 4%)
  • YTD Net Sales: $5,330 million (up 3%)
  • Q3 Operating EBITDA: $279 million (up 13%)
  • YTD Operating EBITDA: $990 million (up 22%)
  • Growth driven by herbicides, fungicides, and biologicals; modest price decline offset by strong volume.

Balance Sheet and Capital Allocation:

• Cash, Equivalents, Marketable Securities: $2,586 million as of September 30, 2025.
• Total Debt: $4,373 million (increase from YE 2024 due to new $500 million 5.125% Senior Notes due 2032 and higher short-term borrowing).
• Total Assets: $42,198 million; Equity: $25,461 million.
• **Leverage remains modest, significant liquidity ($6.3 billion access including undrawn credit facilities).

Shareholder Returns:

• Returned approximately $1.1 billion to shareholders YTD via share buybacks and dividends.
• Repurchased 3.4 million shares in Q3 2025 at an average price of $73.51 per share.
• $2.73 billion remains under the $3 billion 2024 Share Buyback Program.

Risks and Legal Matters:

• Spin-off Announcement: On October 1, 2025, announced intent to separate seed and crop protection into standalone public companies; introduces execution and market risks cited on p. 62.
• PFAS Litigation/Settlements: Ongoing legacy EIDP environmental matters, including $875 million settlement with State of New Jersey, potential further exposures discussed (p. 25-29).
• Other Litigation: Involvement in disputes with Bayer and Inari, plus regulatory investigations and product liability claims.
• Market Risk: Large derivatives portfolio to hedge currency and commodity exposure; sensitivity to foreign exchange rates, price fluctuations, regulatory and litigation uncertainty.
• Restatement: EIDP restated prior cash flow statements for 2024 due to corrections in intercompany transactions.

Operational and Strategic Highlights:

• Positive pricing actions and productivity improvements offset increased compensation and R&D expenses.
• Working capital requirements remain high due to large customer financing programs and seasonal inventory build.
• Strong access to capital markets, cash flow supports ongoing investments, dividend policy, and buybacks.

Guidance/Forward-Looking:

• Management expects continued repurchases (~$1 billion annually), and notes risks associated with proposed spin-off and ongoing litigation.
• Closely monitoring regulatory actions, especially regarding genetically modified seed approvals and potential federal agency funding disruptions.

Conclusion: Corteva delivered double-digit sales and EBITDA growth in Q3 and YTD, with strong operational execution and effective cost controls. However, investors should monitor risks related to the proposed business separation, legacy environmental liabilities, and pending legal proceedings. The balance sheet is robust, with ample liquidity and capital to support continued returns and strategic flexibility.

Visit Publicview AI to search and analyze millions of SEC filings using AI.